The Abbott Alinity m SARS-CoV-2 assay has become an essential part of COVID-19 testing globally. This polymerase chain reaction (PCR) based test allows for the qualitative detection of SARS-CoV-2, the virus that causes COVID-19. With its high sensitivity and specificity, quick turnaround time, and ability to run high volumes of tests, the Alinity m SARS-CoV-2 test has supported population-scale testing during the pandemic. An Overview of the Alinity m Platform The Abbott Alinity m system is an automated molecular diagnostics platform capable of performing sample preparation, amplification, detection, and result calculation for a variety of infectious disease tests. Key features of the Alinity m platform include: Fully automated sample-to-result workflow Random access for stat testing capabilities Onboard capability for up to 3 assays simultaneously High throughput with ability to run up to 1,080 tests in a 24 hour period The Alinity m leverages Abbott’s sensitive polymerase
Nhận xét
Đăng nhận xét